WallStSmart
AVNS

Avanos Medical Inc

NYSE: AVNS · HEALTHCARE · MEDICAL DEVICES

$24.64
-0.06% today

Updated 2026-04-30

Market cap
$1.15B
P/E ratio
P/S ratio
1.64x
EPS (TTM)
$-1.57
Dividend yield
52W range
$9 – $25
Volume
1.4M

Avanos Medical Inc (AVNS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+7.5%
Last 4 quarters
Revenue YoY growth
+0.7%
Most recent quarter
EPS YoY growth
-32.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.7%
2026-02-24
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-24$0.29+16.0%$15.23$14.36-5.7%
2025-11-05$0.22+22.2%$11.30$11.18-1.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.25$0.29+16.0%$180.90M+0.7%
2025-09-30$0.18$0.22+22.2%$177.80M+4.3%
2025-06-30$0.15$0.17+13.3%$175.00M+1.9%
2025-03-31$0.18$0.14-21.5%$167.50M+0.8%
2024-12-31$0.40$0.43+8.4%$179.60M+3.6%
2024-09-30$0.35$0.36+2.9%$170.40M-0.5%
2024-06-30$0.29$0.29+0.0%$171.70M+1.4%
2024-03-31$0.21$0.19-9.5%$166.10M+4.3%
2023-12-31$0.37$0.32-13.5%$173.30M
2023-09-30$0.28$0.42+50.0%$171.30M
2023-06-30$0.30$0.37+23.3%$169.40M
2023-03-31$0.27$0.27+0.0%$159.30M

Frequently asked questions

Has Avanos Medical Inc beaten earnings estimates?
Avanos Medical Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +7.5% over the last 4 quarters.
How does AVNS stock react to earnings?
AVNS stock has moved an average of -3.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Avanos Medical Inc's revenue growth rate?
Avanos Medical Inc reported year-over-year revenue growth of +0.7% in its most recent quarter, with EPS growing -32.6% year-over-year.